Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anthony Russo

Orthopaedic Surgery of the Spine Great Falls, MT Medical Doctor

NPI 1164402707 CMS profile 234173

1401 25Th St S, Great Falls, MT 59405

Open in the dashboard

General payments

$287,963

283 records reported · program years 2019–2025

Research payments

$178,834

Paid to them · 24 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$945 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Anthony Russo of Great Falls, MT is reported in the CMS Open Payments database as having received $287,963 across 283 general payments and $178,834 in research payments paid to them. Separately, studies naming them as principal investigator received $945 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 89th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $41,268 46
2024 General $35,156 28
2023 General $51,563 54
2022 General $36,541 37
2022 Research $15,960 1
2021 General $37,136 44
2021 Research $14,265 6
2020 General $30,067 19
2020 Research $111,853 15
2019 General $56,233 55
2019 Research $36,756 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anthony Russo
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Anthony Russo were reported at $41,268. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Anthony Russo Orthopaedic Surgery of the Spine median Middle half National median
2019 $56,233 $2,106 $337–$18,608 $163
2020 $30,067 $1,213 $156–$15,082 $114
2021 $37,136 $1,834 $271–$15,617 $132
2022 $36,541 $2,015 $320–$17,036 $149
2023 $51,563 $1,925 $336–$14,599 $160
2024 $35,156 $2,110 $341–$12,483 $164
2025 $41,268 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $210,689 195 payments
  2. Orthofix Medical, Inc. $50,330 39 payments
  3. Seaspine Orthopedics Corporation $19,995 27 payments
  4. SurGenTec $2,250 1 payment
  5. Medtronic USA, Inc. $1,813 6 payments
  6. MiRus, LLC $1,566 2 payments
  7. Cerapedics, Inc. $1,023 7 payments
  8. Centinel Spine, LLC $94 1 payment
  9. Nevro Corp. $82 1 payment
  10. Baxter Healthcare $50 1 payment
  11. Other $71 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $161,082 55 payments
  2. Royalty or License $62,364 28 payments
  3. Travel and Lodging $36,572 77 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $20,925 6 payments
  5. Food and Beverage $6,795 115 payments
  6. Entertainment $127 1 payment
  7. Education $99 1 payment
Products named General payments · program years 2019–2025
  1. Precision TLIF $45,228 14 payments
  2. Trinity Elite $32,743 19 payments
  3. Graft Delivery $20,139 8 payments
  4. Troch Nail $16,195 7 payments
  5. TLIF $13,613 5 payments
  6. AUTOBAHN $12,595 4 payments
  7. InstaFill Biologics $11,322 5 payments
  8. InstaFill Biologics $10,705 6 payments
  9. CREO MCS, Fenestrated, Sideloading $10,525 4 payments
  10. CREO $10,377 3 payments
  11. Other $96,822 185 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Orthofix Medical, Inc. $178,834 24 payments

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

49

Median for Orthopedic Surgery: 203

Drug cost

$529

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 25 $362
Gabapentin Generic 24 $166

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$213,172

Medicare's payments for the services billed

Medicare patients

135

Average age 73

Services billed

639

75 women, 60 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 64%
Osteoporosis 30%
Depression 28%
Diabetes 22%
COPD 19%
Ischemic heart disease 16%
Chronic kidney disease 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

307 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record